Lombard & Geliebter, LLP
Contact Us 305 Broadway, 7th Floor
New York, NY 10007
212-520-1172
  • Home
  • Our Firm
  • Practice Areas
    • Trademark Law
      • Trademark Clearance & Registration (U.S. & International)
      • Trademark & Unfair Competition Litigation
      • Trademark Trial & Appeal Board Proceedings
      • Trademark Licensing
    • Patent Law
      • Patent Prosecution
      • Patent litigation
      • Hatch-Waxman Litigation
    • Copyright Law
      • Copyright litigation
      • Digital Millenium Copyright Act Compliance (DMCA)
      • Copyright Registration
    • IP Litigation & Enforcement
      • Trademark & Unfair Competition Litigation
      • Patent Litigation
      • Hatch-Waxman Litigation
      • Copyright Litigation
      • Anti-counterfeiting litigation
      • Section 337 Proceedings with International Trade Commission
    • Domain Name Disputes
      • Uniform Domain Name Dispute Resolution Policy actions (UDRP)
      • Anticybersquatting Consumer Protection Act cases (ACPA)
    • Licensing Agreements
    • Social Media, New Media & Internet Law
      • Privacy & Terms of Service policies
      • IP & DMCA Compliance policies
      • Web development agreements
    • Software Development & Licensing
    • Trade Secrets, Corporate & Other Related IP Services
      • Non-Disclosure Agreements
      • Non-Compete Agreements
      • Confidentiality Agreements
      • IP Due Diligence
      • Corporate Formation
    • Art Law
  • Our People
    • Darren M. Geliebter
    • G. Mathew Lombard
    • Eric J. Huang
    • Alex Golimbu
    • Al J. Daniel, Jr.
    • Michael J. Brown
    • Donna M. Hart
    • Stuart P. Suskind PhD
  • News & Events
    • Articles
  • Resources
    • Legislation
    • Federal IP Administration
    • Courts
    • State Trademark Administration
    • Associations
  • Contact Us
    • Directions

Pharmaceutical Trademarks

  • FDA MAPP 6720.2- Procedures for Handling Requests for Proprietary Name Review
  • FDA PDUFA Pilot Project Proprietary Name Review Concept Paper
  • WHO's Use of Stems in Selection of INNs for Pharmaceutical Substances 2009
  • EMEA Guideline on the Acceptability of Names
  • L&G Client Advisory – New Pharmaceutical & Name Safety Search

L&G on Twitter

Tweets by @LGMarks
  • Home
  • Our Firm
  • Practice Areas
  • Our People
  • News & Events
  • Resources
  • Contact Us
  • Blog
Mail facebook twitter linked in rss read our blogs
305 Broadway, 7th Floor New York, NY 10007

© 2019 Lombard & Geliebter, LLP. All rights reserved.
This Custom WebShop™ website is designed and powered by NextClient.com.